Business hours

Monday - Friday 8am to 4:30pm
After hours or weekends if required by protocol

Horario de oficina

Lunes - Vienes 8 am a 4.30 pm
Fuera de horario o fines de semana si lo requiere el protocolo


(305) 456-9062


Clinical studies

Oral Contraceptives

A Phase 3, Single-Arm, Open-Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids orEndometriosis Who Are 18 to 50 Years of Age and at Risk for Pregnancy.

Age group: From 18 to 50 years old
Gender: Female
Duration: Up to 2 years approximately
Compensation: Up to $2,200

About the Study
The purpose of this clinical study is to evaluate how safe and how well this drug is to prevent pregnancy in adult women with uterine fibroid or endometriosis. The study drug is
FDA-approved to manage heavy menstrual bleeding associated with endometriosis.

Who can Participate?
Be a woman 18 to 50 years of age and have regular menstrual cycles that are between 21 and 35 days (approximately 1 week of bleeding each month and 3-4 weeks of no bleeding between
periods). Have a diagnosis of either uterine fibroids with heavy menstrual bleeding or endometriosis with moderate-severe pain. Be sexually active and at risk of pregnancy. Be willing to use the study drug as the only method of birth control for one year.

Where is the study taking place?
The study is being conducted at our site in Palmetto Medical Plaza


Current Clinical Research Study Request

Enter your full legal name

Clinical studies



Monday - Friday 9am to 4:30pm
After hours or weekends if required by protocol

Main Line

(305) 456-9141

24 Hour Phone

786) 214-1433


Palmetto Medical Plaza 7100 West 20th Avenue, Suite 411 Hialeah, FL 33016

Email Us